MFDS — authorised 19 November 1991
- Marketing authorisation holder: PFIZER PHARMS
- Status: likely_approved
🇰🇷 Accupril in South Korea
MFDS authorised Accupril on 19 November 1991
Marketing authorisation
Accupril in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Accupril approved in South Korea?
Yes. MFDS authorised it on 19 November 1991.
Who is the marketing authorisation holder for Accupril in South Korea?
PFIZER PHARMS holds the South Korean marketing authorisation.